Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Simulations Plus stock

SLP
US8292141053
924294

Price

27.78
Today +/-
+0.52
Today %
+2.04 %
P

Simulations Plus stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Simulations Plus stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Simulations Plus stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Simulations Plus stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Simulations Plus's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Simulations Plus Stock Price History

DateSimulations Plus Price
11/1/202427.78 undefined
10/31/202427.22 undefined
10/30/202428.68 undefined
10/29/202429.75 undefined
10/28/202430.90 undefined
10/25/202430.68 undefined
10/24/202430.96 undefined
10/23/202433.98 undefined
10/22/202434.25 undefined
10/21/202434.28 undefined
10/18/202434.15 undefined
10/17/202433.29 undefined
10/16/202432.27 undefined
10/15/202431.50 undefined
10/14/202431.72 undefined
10/11/202431.24 undefined
10/10/202430.36 undefined
10/9/202430.27 undefined
10/8/202430.19 undefined
10/7/202429.82 undefined

Simulations Plus Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Simulations Plus, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Simulations Plus from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Simulations Plus’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Simulations Plus. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Simulations Plus’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Simulations Plus’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Simulations Plus’s growth potential.

Simulations Plus Revenue, EBIT and net profit per share

DateSimulations Plus RevenueSimulations Plus EBITSimulations Plus Net Income
2030e200.84 M undefined0 undefined0 undefined
2029e173.14 M undefined48.48 M undefined0 undefined
2028e148.61 M undefined38.64 M undefined37.59 M undefined
2027e127.57 M undefined30.62 M undefined30.11 M undefined
2026e103.94 M undefined21.1 M undefined18.44 M undefined
2025e91.8 M undefined15.72 M undefined13.74 M undefined
2024e71.74 M undefined8.25 M undefined10.15 M undefined
202359.58 M undefined8.73 M undefined9.96 M undefined
202253.91 M undefined14.91 M undefined12.48 M undefined
202146.47 M undefined11.26 M undefined9.78 M undefined
202041.59 M undefined11.6 M undefined9.33 M undefined
201933.97 M undefined10.65 M undefined8.58 M undefined
201829.67 M undefined10.3 M undefined8.93 M undefined
201724.14 M undefined8.26 M undefined5.79 M undefined
201619.97 M undefined7.23 M undefined4.95 M undefined
201518.31 M undefined5.86 M undefined3.84 M undefined
201411.46 M undefined4.44 M undefined3.03 M undefined
201310.07 M undefined4.07 M undefined2.89 M undefined
20129.45 M undefined3.61 M undefined3.03 M undefined
20118.74 M undefined3.53 M undefined2.71 M undefined
201010.71 M undefined2.87 M undefined2.16 M undefined
20099.14 M undefined1.81 M undefined1.41 M undefined
20088.97 M undefined2.18 M undefined1.73 M undefined
20078.86 M undefined2.5 M undefined1.47 M undefined
20065.86 M undefined830,000 undefined680,000 undefined
20054.75 M undefined300,000 undefined260,000 undefined
20045.21 M undefined630,000 undefined840,000 undefined

Simulations Plus Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e2030e
2222233345545889108910111819242933414653597191103127148173200
-----50.00--33.3325.00--20.0025.0060.00-12.5011.11-20.0012.5011.1110.0063.645.5626.3220.8313.7924.2412.2015.2211.3220.3428.1713.1923.3016.5416.8915.61
50.0050.0050.0050.00-33.3366.6766.6750.0060.0060.0075.0080.0075.0075.0066.6780.0087.5077.7880.0081.8272.2278.9570.8372.4172.7373.1776.0981.1379.66-------
1111012223334666877891315172124303543470000000
000-1-2000010002212334457810101111148815213038480
----50.00-100.00----20.00---25.0025.0011.1120.0037.5033.3340.0036.3627.7836.8433.3334.4830.3026.8323.9126.4213.5611.2716.4820.3923.6225.6827.75-
000-1-200002000111223233458899129101318303700
----100.00-----------100.00-50.00-33.3350.00-33.3325.0060.00-12.50-33.33-25.0011.1130.0038.4666.6723.33--
-------------------------------------
-------------------------------------
9.569.569.5610.1113.413.5113.5413.5814.114.9615.5815.9216.2917.9618.1417.1916.5116.0816.1516.3216.4117.0317.2117.5217.8618.0618.5420.7420.7520.470000000
-------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Simulations Plus Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Simulations Plus is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (k)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (k)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
00.22.20.20.100.200.30.71.81.74.55.97.59.610.212.710.28.68.686.29.411.4116123.6128.2115.5
0.30.20.40.40.60.50.40.91.41.71.11.62.12.11.91.31.21.51.91.71.6347.58.310.51313.810.2
01000000000000000200200000000000000
1001002003002002002002002004003002002003003006000000000000000
0.10.10000000.10.30.20.40.40.50.60.61.60.50.91.21.41.72.40.91.52.62.74.84.7
0.50.72.80.90.90.70.81.123.13.43.97.28.810.312.313.214.71311.511.612.712.617.821.2129.1139.3146.8130.4
000.20.20.10.10.10.10.10.10.10.10.10.10.10.100.10.10.10.40.30.30.30.31.43.12.11.9
0000000000000800000000000000000
0000000030000000000000000000000
0.20.20.70.80.60.60.30.30.40.60.91.51.61.822.22.22.639.310.61015.114.713.32524.626.232.8
000000000000000000004.84.810.410.410.412.912.912.919.1
00.1000.10.1001.31.21.3100000.4000000000.10.10.41.9
0.20.30.910.80.80.40.42.11.92.32.61.72.72.12.32.62.73.19.415.815.125.825.42439.440.741.655.7
0.713.71.91.71.51.21.54.155.76.58.911.512.414.615.817.416.120.927.427.838.443.245.2168.5180188.4186.1
                                                         
00000000000000000000000000133.4138.5145
004.64.64.64.64.74.74.755.15.35.86.35.65.94.24.64.86.19.711.412.113.515.3128.5000
0.20.2-1.2-3.3-3.9-4.2-4.4-3.9-1.4-0.5-0.30.41.93.657.29.910.59.49.39.811.313.718.522.427.432.44025.2
00000000000000000000000001000-300-100
00000000000000000000000000000
0.20.23.41.30.70.40.30.83.34.54.85.77.79.910.613.114.115.114.215.419.522.725.83237.7156165.8178.2170.1
100200100300200200300100200200100200200200200200200200100100200100200400200300400200100
0.30.30.20.20.50.60.60.60.40.30.50.50.70.60.70.60.30.40.40.50.60.611.21.62.764.65.5
000000.1000.100.10.10.10.10.10.40.70.90.10.82.91.40.83.32.92.45.22.96.4
10030001001001001000000000000000000000000
00000000000000000000000000000
0.50.80.30.60.8110.70.70.50.70.810.911.21.21.50.61.43.72.124.94.75.411.67.712
0010000000000000000000000000000
00.100000000000.20.70.80.40.70.81.12.43.234.93.22.72.41.71.50
00000000.1000000000001.8105.73.304.50.90.94.1
00.10.100000.100000.20.70.80.40.70.81.14.24.2310.66.52.76.92.62.44.1
0.50.90.40.60.8110.80.70.50.70.81.21.61.81.61.92.31.75.67.95.112.611.47.412.314.210.116.1
0.71.13.81.91.51.41.31.6455.56.58.911.512.414.71617.415.92127.427.838.443.445.1168.3180188.3186.2
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Simulations Plus provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Simulations Plus's financial health and stability.

Assets

Simulations Plus's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Simulations Plus must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Simulations Plus after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Simulations Plus's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
000-1-200002000111223233458899129
000000000000000000001112222333
000000000-1,0000001,0000000001,000000-1,0000000-2,000
0000000000000000000-100-1-1-10-20-25
000000000000000000000001123879
000000000000000000000000000000
000000000000000000010022222133
000-1-1000000112222332575691110191721
000000000000-100000-1-1-1-1-1-1-2-1-2-4-3-4
000000000000-10-100-10-1-3-3-1-4-2-1-75-2647
00000000000000000010-2-10-200-72-22811
000000000000000000000000000000
000000000000000000000000000000
00050000000000000-100000000010-18
00040000000000000-1-2-3-2-4-3-4-3-7102-4-7-23
000-10000000000001000000-10-4105-1-30
000000000000000000-2-4-3-3-3-3-4-4-4-4-4-4
0001-100000010211202-2-100-13237-12145
-0.020.040.02-2.11-1.95-0.110.010.12-0.020.230.310.89-0.222.341.671.771.972.682.641.383.925.894.195.326.969.688.3314.6213.9317.59
000000000000000000000000000000

Simulations Plus stock margins

The Simulations Plus margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Simulations Plus. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Simulations Plus.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Simulations Plus's sales revenue. A higher gross margin percentage indicates that the Simulations Plus retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Simulations Plus's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Simulations Plus's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Simulations Plus's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Simulations Plus. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Simulations Plus's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Simulations Plus Margin History

Simulations Plus Gross marginSimulations Plus Profit marginSimulations Plus EBIT marginSimulations Plus Profit margin
2030e80.48 %0 %0 %
2029e80.48 %28 %0 %
2028e80.48 %26 %25.29 %
2027e80.48 %24 %23.61 %
2026e80.48 %20.3 %17.74 %
2025e80.48 %17.12 %14.97 %
2024e80.48 %11.49 %14.14 %
202380.48 %14.65 %16.72 %
202279.91 %27.66 %23.15 %
202177.19 %24.23 %21.05 %
202074.39 %27.89 %22.43 %
201973.42 %31.35 %25.26 %
201873.04 %34.72 %30.1 %
201773.86 %34.22 %23.99 %
201676.97 %36.2 %24.79 %
201576.02 %32 %20.97 %
201485.78 %38.74 %26.44 %
201383.61 %40.42 %28.7 %
201284.02 %38.2 %32.06 %
201182.15 %40.39 %31.01 %
201076.28 %26.8 %20.17 %
200974.62 %19.8 %15.43 %
200876.59 %24.3 %19.29 %
200776.52 %28.22 %16.59 %
200672.53 %14.16 %11.6 %
200568.42 %6.32 %5.47 %
200470.06 %12.09 %16.12 %

Simulations Plus Stock Sales Revenue, EBIT, Earnings per Share

The Simulations Plus earnings per share therefore indicates how much revenue Simulations Plus has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Simulations Plus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Simulations Plus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Simulations Plus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Simulations Plus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Simulations Plus Revenue, EBIT and net profit per share

DateSimulations Plus Sales per ShareSimulations Plus EBIT per shareSimulations Plus Earnings per Share
2030e10.04 undefined0 undefined0 undefined
2029e8.65 undefined0 undefined0 undefined
2028e7.43 undefined0 undefined1.88 undefined
2027e6.38 undefined0 undefined1.5 undefined
2026e5.19 undefined0 undefined0.92 undefined
2025e4.59 undefined0 undefined0.69 undefined
2024e3.59 undefined0 undefined0.51 undefined
20232.91 undefined0.43 undefined0.49 undefined
20222.6 undefined0.72 undefined0.6 undefined
20212.24 undefined0.54 undefined0.47 undefined
20202.24 undefined0.63 undefined0.5 undefined
20191.88 undefined0.59 undefined0.48 undefined
20181.66 undefined0.58 undefined0.5 undefined
20171.38 undefined0.47 undefined0.33 undefined
20161.16 undefined0.42 undefined0.29 undefined
20151.08 undefined0.34 undefined0.23 undefined
20140.7 undefined0.27 undefined0.18 undefined
20130.62 undefined0.25 undefined0.18 undefined
20120.59 undefined0.22 undefined0.19 undefined
20110.54 undefined0.22 undefined0.17 undefined
20100.65 undefined0.17 undefined0.13 undefined
20090.53 undefined0.11 undefined0.08 undefined
20080.49 undefined0.12 undefined0.1 undefined
20070.49 undefined0.14 undefined0.08 undefined
20060.36 undefined0.05 undefined0.04 undefined
20050.3 undefined0.02 undefined0.02 undefined
20040.33 undefined0.04 undefined0.05 undefined

Simulations Plus business model

Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.com.

Simulations Plus Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Simulations Plus Revenue by Segment

Segmente202320222021202020192018201720162015
Software36.52 M USD32.64 M USD-------
Services23.06 M USD21.26 M USD-------
Consulting Services--18.8 M USD------
Software Licenses--945,000 USD------
Services23.06 M USD21.26 M USD-------
Consulting Services---20 M USD15.49 M USD----
Software--27.67 M USD------
Service--18.8 M USD------
Software licenses1.15 M USD1.06 M USD-------
Software Licenses---919,344 USD1.05 M USD----
Simulations Plus, Inc.---21.96 M USD19.59 M USD17.55 M USD15.6 M USD14.42 M USD13.09 M USD
Operating Segments--46.47 M USD41.59 M USD-----
Software36.52 M USD32.64 M USD-------
Cognigen--10.55 M USD11.11 M USD9.32 M USD7.86 M USD7.3 M USD5.55 M USD5.23 M USD
Services23.06 M USD21.26 M USD-------
Simulations--25.14 M USD------
D I L Isym--6.12 M USD6.95 M USD-----
DILIsym----5.07 M USD4.26 M USD1.24 M USD--
Lixoft--4.66 M USD1.58 M USD-----
Eliminations---------

Simulations Plus Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Simulations Plus Revenue by Segment

DateAmericasAsiaAsia PacificEMEAEuropeNorth AmericaNorth And South AmericaSouth America
202340.82 M USD-7.05 M USD11.71 M USD----
202237.68 M USD-5.84 M USD10.39 M USD----
2021-6.01 M USD-7.91 M USD--32.55 M USD-
2020-6.09 M USD--5.83 M USD-29.67 M USD-
2019-5.57 M USD--5.83 M USD22.52 M USD--
2018-5.52 M USD--5.28 M USD18.85 M USD-30,000 USD
2017-236,000 USD--151,000 USD851,000 USD--
2016-----5.55 M USD--
2015-----5.23 M USD--
2014-2.82 M USD--2.98 M USD5.63 M USD-26,000 USD
2013-1,882 USD--2,980 USD5,203 USD-6 USD

Simulations Plus SWOT Analysis

Strengths

Simulations Plus Inc has established itself as a leader in the field of pharmaceutical software and consulting services.

The company has a strong reputation for providing high-quality and reliable solutions that help improve drug discovery and development processes.

Simulations Plus Inc has a diverse customer base, including leading pharmaceutical companies, regulatory agencies, and academic institutions.

Weaknesses

Despite its strong reputation, Simulations Plus Inc faces competition from other software and consulting companies operating in the same industry.

The company's reliance on a few key customers for a significant portion of its revenue poses a potential risk.

Simulations Plus Inc may face challenges in adapting to rapidly changing technological advancements in the pharmaceutical industry.

Opportunities

The increasing demand for innovative software and consulting solutions in drug development provides growth opportunities for Simulations Plus Inc.

The company can expand its market presence by targeting emerging pharmaceutical markets in regions such as Asia-Pacific and Latin America.

Collaboration with research institutions and government agencies can open avenues for new projects and partnerships.

Threats

Simulations Plus Inc may face potential threats from regulatory changes that affect the drug development and approval process.

The emergence of new competitors with advanced technology and lower pricing can pose a threat to the company's market share.

Fluctuations in exchange rates and economic instability can impact the company's international operations and profitability.

Simulations Plus Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Simulations Plus historical P/E ratio, EBIT multiple, and P/S ratio

Simulations Plus shares outstanding

The number of shares was Simulations Plus in 2023 — This indicates how many shares 20.47 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Simulations Plus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Simulations Plus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Simulations Plus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Simulations Plus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Simulations Plus stock splits

In Simulations Plus's history, there have been no stock splits.

Simulations Plus dividend history and estimates

In 2023, Simulations Plus paid a dividend amounting to 0.24 USD. Dividend means that Simulations Plus distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Simulations Plus provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Simulations Plus’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Simulations Plus's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Simulations Plus Dividend History

DateSimulations Plus Dividend
2030e0.25 undefined
2029e0.25 undefined
2028e0.25 undefined
2027e0.25 undefined
2026e0.25 undefined
2025e0.25 undefined
2024e0.25 undefined
20230.24 undefined
20220.24 undefined
20210.24 undefined
20200.24 undefined
20190.24 undefined
20180.24 undefined
20170.21 undefined
20160.2 undefined
20150.2 undefined
20140.25 undefined
20130.1 undefined
20120.34 undefined

Simulations Plus dividend payout ratio

In 2023, Simulations Plus had a payout ratio of 46.35%. The payout ratio indicates the percentage of the company's profits that Simulations Plus distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Simulations Plus represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Simulations Plus could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Simulations Plus's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Simulations Plus Payout Ratio History

DateSimulations Plus Payout ratio
2030e45.02 %
2029e45.11 %
2028e44.85 %
2027e45.09 %
2026e45.4 %
2025e44.05 %
2024e45.81 %
202346.35 %
202240 %
202151.06 %
202048 %
201950 %
201848 %
201763.64 %
201668.97 %
201586.96 %
2014138.89 %
201355.56 %
2012200 %
201146.35 %
201046.35 %
200946.35 %
200846.35 %
200746.35 %
200646.35 %
200546.35 %
200446.35 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Simulations Plus.

Simulations Plus latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240.04 0.04  (-9.91 %)2024 Q4
6/30/20240.15 0.15  (-0.99 %)2024 Q3
3/31/20240.19 0.2  (4.22 %)2024 Q2
12/31/20230.1 0.1  (-0.99 %)2024 Q1
9/30/20230.19 0.02  (-89.2 %)2023 Q4
6/30/20230.21 0.2  (-2.63 %)2023 Q3
3/31/20230.18 0.2  (10.01 %)2023 Q2
12/31/20220.09 0.06  (-30.15 %)2023 Q1
9/30/20220.07 0.04  (-43.42 %)2022 Q4
6/30/20220.18 0.2  (13.12 %)2022 Q3
1
2
3
4
5
...
9

Eulerpool ESG Scorecard© for the Simulations Plus stock

Eulerpool World ESG Rating (EESG©)

32/ 100

🌱 Environment

32

👫 Social

53

🏛️ Governance

10

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees49
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Simulations Plus shareholders

%
Name
Stocks
Change
Date
17.39926 % Woltosz (Walter S)3,481,592-20,00010/1/2024
11.35085 % BlackRock Institutional Trust Company, N.A.2,271,306-46,6336/30/2024
9.67440 % Conestoga Capital Advisors, LLC1,935,848-327,8169/30/2024
5.74973 % The Vanguard Group, Inc.1,150,52117,7556/30/2024
4.17658 % Ranger Investment Management, L.P.835,7339056/30/2024
3.05522 % State Street Global Advisors (US)611,350-6,4526/30/2024
2.14740 % Geode Capital Management, L.L.C.429,69423,7156/30/2024
2.12204 % Ophir Asset Management Pty Ltd424,621-15,1086/30/2024
2.06899 % Dimensional Fund Advisors, L.P.414,00537,9926/30/2024
1.62702 % Tributary Capital Management, LLC325,567115,1229/30/2024
1
2
3
4
5
...
10

Simulations Plus Executives and Management Board

Mr. Shawn O'Connor(64)
Simulations Plus Chief Executive Officer
Compensation 1.94 M
Mr. William Frederick(61)
Simulations Plus Chief Financial Officer, Chief Operating Officer, Secretary
Compensation 880,897
Mr. John Dibella(44)
Simulations Plus President - PBPK, Regulatory Strategies, Cheminformatics Solutions
Compensation 728,135
Ms. Jill Fiedler-Kelly(55)
Simulations Plus President - Clinical Pharmacology and Pharmacometric Services
Compensation 722,102
Dr. Brett Howell(40)
Simulations Plus President - Quantitative Systems Pharmacology Solutions
Compensation 649,999
1
2
3

Simulations Plus Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Catalent Stock
Catalent
SupplierCustomer0,800,060,250,440,08-0,34
Thermo Fisher Scientific Stock
Thermo Fisher Scientific
SupplierCustomer0,740,810,650,540,09-0,62
Charles River Labs Intl Stock
Charles River Labs Intl
SupplierCustomer0,560,690,460,190,07-0,56
Eurofins Scientific Stock
Eurofins Scientific
SupplierCustomer0,430,600,680,570,10-0,65
Evotec Stock
Evotec
SupplierCustomer0,170,180,270,060,04-0,50
WuXi AppTec Co H Stock
WuXi AppTec Co H
SupplierCustomer-0,050,480,600,390,23-0,30
Dassault Systemes Stock
Dassault Systemes
SupplierCustomer-0,160,510,250,430,31-0,67
Hangzhou Tigermed H Stock
Hangzhou Tigermed H
SupplierCustomer-0,170,630,570,380,20
Pharmaron Beijing H Stock
Pharmaron Beijing H
SupplierCustomer-0,170,750,440,260,22-0,20
Amazon.com Stock
Amazon.com
SupplierCustomer-0,240,140,380,360,24-0,15
1

Most common questions regarding Simulations Plus

What values and corporate philosophy does Simulations Plus represent?

Simulations Plus Inc represents values of innovation, scientific excellence, and customer satisfaction. With a corporate philosophy focused on advancing pharmaceutical research and enhancing drug development, Simulations Plus Inc strives to provide cutting-edge software and consulting services. By combining advanced technologies and domain knowledge, the company facilitates cost-effective and efficient drug discovery and development processes. Simulations Plus Inc is committed to delivering high-quality solutions, fostering collaborative relationships, and continuously improving its products and services.

In which countries and regions is Simulations Plus primarily present?

Simulations Plus Inc is primarily present in the United States.

What significant milestones has the company Simulations Plus achieved?

Simulations Plus Inc has achieved significant milestones throughout its history. Some notable accomplishments include the development and release of their industry-leading software solutions, such as GastroPlus™ and DDDPlus™, which have gained widespread recognition and adoption in the pharmaceutical industry. The company has also formed strategic partnerships and collaborations with top pharmaceutical companies, further establishing its presence and credibility in the market. Additionally, Simulations Plus Inc has a strong track record of achieving consistent revenue growth and delivering value to its shareholders. These achievements reflect the company's commitment to innovation, excellence, and meeting the evolving needs of the life sciences industry.

What is the history and background of the company Simulations Plus?

Simulations Plus Inc is a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries. Established in 1996, the company has amassed extensive expertise in the field. Simulations Plus Inc has developed a strong reputation for its cutting-edge technology and innovative solutions, helping pharmaceutical companies optimize drug discovery and development processes. With a focus on increasing efficiency and reducing costs, Simulations Plus Inc has become a trusted partner for numerous organizations worldwide. The company's commitment to excellence has earned them recognition and a loyal customer base. Simulations Plus Inc continues to drive advancements in the industry, delivering impactful software solutions that streamline drug development.

Who are the main competitors of Simulations Plus in the market?

The main competitors of Simulations Plus Inc in the market include Certara, Inc and Dassault Systèmes.

In which industries is Simulations Plus primarily active?

Simulations Plus Inc is primarily active in the pharmaceutical and biotechnology industries. With a focus on simulation software and consulting services, the company provides cutting-edge solutions for drug discovery and development. Simulations Plus Inc's expertise in modeling and simulation technologies helps pharmaceutical companies optimize their drug formulation and dosage strategies. By leveraging their industry-leading software platforms, Simulations Plus Inc supports the efficient research and development of new therapies, enhancing the overall success and effectiveness of pharmaceutical companies.

What is the business model of Simulations Plus?

The business model of Simulations Plus Inc revolves around providing software and consulting services for pharmaceutical research and development. As a leading provider in the field of drug discovery and development, Simulations Plus Inc aims to enhance the efficiency and effectiveness of the pharmaceutical industry through their innovative solutions. By utilizing computer modeling and simulation software, the company assists in predicting and optimizing drug properties, interactions, and outcomes. This enables scientists and researchers to make informed decisions throughout the drug development process, leading to improved efficacy, safety, and reduced costs. Simulations Plus Inc's comprehensive solutions cater to the needs of pharmaceutical companies, regulatory agencies, and academia worldwide.

What is the P/E ratio of Simulations Plus 2024?

The Simulations Plus P/E ratio is 56.05.

What is the P/S ratio of Simulations Plus 2024?

The Simulations Plus P/S ratio is 7.93.

What is the Quality Investing of Simulations Plus?

The Quality Investing for Simulations Plus is 7/10.

What is the revenue of Simulations Plus 2024?

The expected Simulations Plus revenue is 71.74 M USD.

How high is the profit of Simulations Plus 2024?

The expected Simulations Plus profit is 10.15 M USD.

What is the business model of Simulations Plus

Simulations Plus Inc. is a leading company in the field of simulation technology and software development. It provides solutions for researchers and experts in various industries, including biotechnology, pharmaceuticals, agriculture, food technology, and more. The company offers a range of products and tools for data analysis and innovative strategy development to bring new products and applications to the market. Some of its notable products include PK-SIM, MoBi, ADMET Predictor, GastroPlus, DILIsym, and MedChem Studio. Simulations Plus also offers solutions for the agricultural sector, such as Cartagenia, Crop Laptop, and Dose Response Toxicology. The company provides training and support to its customers, aiming to optimize their business processes. Its business model focuses on processing and analyzing large data sets to provide relevant insights and support decision-making processes. Simulations Plus aims to expand into new markets and develop products based on the latest technological advancements.

What is the Simulations Plus dividend?

Simulations Plus pays a dividend of 0.24 USD distributed over payouts per year.

How often does Simulations Plus pay dividends?

The dividend cannot currently be calculated for Simulations Plus or the company does not pay out a dividend.

What is the Simulations Plus ISIN?

The ISIN of Simulations Plus is US8292141053.

What is the Simulations Plus WKN?

The WKN of Simulations Plus is 924294.

What is the Simulations Plus ticker?

The ticker of Simulations Plus is SLP.

How much dividend does Simulations Plus pay?

Over the past 12 months, Simulations Plus paid a dividend of 0.24 USD . This corresponds to a dividend yield of about 0.86 %. For the coming 12 months, Simulations Plus is expected to pay a dividend of 0.25 USD.

What is the dividend yield of Simulations Plus?

The current dividend yield of Simulations Plus is 0.86 %.

When does Simulations Plus pay dividends?

Simulations Plus pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Simulations Plus?

Simulations Plus paid dividends every year for the past 0 years.

What is the dividend of Simulations Plus?

For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.9 %.

In which sector is Simulations Plus located?

Simulations Plus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Simulations Plus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Simulations Plus from 8/5/2024 amounting to 0.06 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did Simulations Plus pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Simulations Plus in the year 2023?

In the year 2023, Simulations Plus distributed 0.24 USD as dividends.

In which currency does Simulations Plus pay out the dividend?

The dividends of Simulations Plus are distributed in USD.

All fundamentals about Simulations Plus

Our stock analysis for Simulations Plus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Simulations Plus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.